The Acute Dialysis Quality Initiative--part V: operational characteristics of CRRT.
暂无分享,去创建一个
[1] S. Brunet,et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] R Jenkins,et al. Accuracy of Intravenous Infusion Pumps in Continuous Renal Replacement Therapies , 1992, ASAIO journal.
[3] C. Stoutenbeek,et al. Cytokine Filtration and Adsorption during Pre- and Postdilution Hemofiltration in Four Different Membranes , 1998, Blood Purification.
[4] H. Kierdorf,et al. Is cytokine removal by continuous hemofiltration feasible? , 1999, Kidney international. Supplement.
[5] S. Goldfarb,et al. Proinflammatory cytokines and hemofiltration membranes. , 1994, Journal of the American Society of Nephrology : JASN.
[6] N. Maxvold,et al. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: A prospective comparison between classic hemofiltration and hemofiltration with dialysis , 2000, Critical care medicine.
[7] M. A. Marx,et al. Drug dosing adjustments during continuous renal replacement therapies. , 1998, Kidney international. Supplement.
[8] S. Vas,et al. Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. , 1988, Clinical nephrology.
[9] C. Ronco,et al. Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. , 1995, Critical care medicine.
[10] John P. Johnson,et al. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. , 1998, Critical care medicine.
[11] B. Canaud,et al. Pump assisted continuous venovenous hemofiltration for treating acute uremia. , 1988, Kidney international. Supplement.
[12] D. Inthorn,et al. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure , 1991, The Lancet.
[13] W. Macias,et al. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] A. Sedman,et al. Continuous venovenous hemodiafiltration in infants and children. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] R. Bellomo,et al. Continuous renal replacement therapy: evolution in technology and current nomenclature. , 1998, Kidney international. Supplement.
[16] A. Greenberg,et al. Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. , 1992, ASAIO journal.
[17] M Roberts,et al. Errors in Fluid Balance with Pump Control of Continuous Hemodialysis , 1992, The International journal of artificial organs.
[18] C. Ronco,et al. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] P. Palevsky,et al. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] P. Palevsky,et al. Determinants of Ceftriaxone Clearance by Continuous Venovenous Hemofiltration and Hemodialysis , 2000, Pharmacotherapy.
[21] P. Palevsky,et al. Determinants of Ceftazidime Clearance by Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodialysis , 2000, Antimicrobial Agents and Chemotherapy.
[22] H. Bruining,et al. Cytokine Kinetics (TNF-α, IL-1β, IL-6) during Continuous Hemofiltration: A Laboratory and Clinical Study , 1995 .
[23] J. De Sutter,et al. Cytokine removal during continuous hemofiltration in septic patients. , 1999, Journal of the American Society of Nephrology : JASN.
[24] G. Camussi,et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.